Dr. Honghong Zhu | Colorectal Cancer | Best Researcher Award

Dr. Honghong Zhu | Colorectal Cancer | Best Researcher Award

Zhejiang Chinese Medical University | China

Author Profile

Scopus

Biography of Hong-Hong Zhu, MD, MSc, PhD – Professor of Extraordinary Ability πŸŽ“πŸŒ

🎯 Current Role: Leader in Medical Research

Dr. Hong-Hong Zhu is the Head of the Center for Medical Research at Zhejiang Chinese Medical University Affiliated Four-Province-Bordering Hospital of Traditional Chinese Medicine (Quzhou Hospital of TCM). Her leadership in medical research spans over three decades.

πŸ“œ Educational Background

  • Ph.D. in Epidemiology from Johns Hopkins University (JHU) Bloomberg School of Public Health (2007)
  • Postdoctoral Training at the U.S. National Institutes of Health (NIH)
  • MD & Master’s Degree in Medicine from Zhejiang University
  • M.Sc. from Clemson University

πŸ’‘ Key Contributions: Breast Cancer Etiology Pioneer

Dr. Zhu was the first to propose the Synergistic Interaction Theory for breast cancer, linking environmental carcinogens and exogenous hormone use. Her work has significantly advanced the understanding of cancer causes.

πŸ”¬ Innovator in Colorectal Cancer Prevention

With 32 years of research in colorectal cancer prevention, Dr. Zhu and her team developed cost-effective screening methods that have saved millions of lives worldwide.

πŸ† Academic Achievements and Awards

  • 135 Publications in esteemed journals
  • 35 Awards, including:
    • Best Poster Award (NIH) for breast cancer research (2006)
    • Delta Omega Honor from the U.S. National Public Health Honor Society (2007)
    • Second Place in Scientific Competition in Epidemiology and Public Health (2007)
    • Professor of Extraordinary Ability (2015)
    • Sigma Xi Scientific Research Honor (2024)

πŸ“š Editor and Peer Reviewer

  • Editor-in-Chief of the Journal of GHR (since 2015)
  • Peer Reviewer for academic journals for over 20 years
  • Grant Reviewer for the U.S. Department of Health and Human Services (12 years)

Dr. Hong-Hong Zhu’s contributions to medical research have made her a global figure in epidemiology and cancer prevention.

πŸ” Conclusion

With over three decades of research in epidemiology and disease prevention, Dr. Hong-Hong Zhu has made groundbreaking contributions in breast and colorectal cancer research. Her innovative approaches to cancer screening and prevention have been life-saving on a global scale. She remains a recognized leader in public health, continuing to inspire through her research, publications, and numerous honors. 🌟

 

πŸ“ŠπŸ”¬NOTABLE PUBLICATION:

 

  • Combining FITs and HRFQ with colonoscopy improve the cost-effectiveness of a 9-year mass colorectal cancer screening program
    Authors: Cai, S.-R., Huang, Y.-Q., Li, Q.-R., Yang, J.-H., Zheng, S.
    Journal: ESMO Open
    Year: 2024

 

  • Sex difference in alcohol consumption associated with colorectal cancer risk in Quzhou, China: A nested case-control study
    Authors: Lai, S.-M., Zhu, H.-H., Gan, Z.-J., Wang, Z.-C., Liao, X.-F.
    Journal: Preventive Medicine Reports
    Year: 2024

 

  • Antibody responses to an inactivated SARS-CoV-2 vaccine in individuals aged from 50 to 102 years
    Authors: Zhu, H.-H., Sun, G.-Q., Wu, J.-Y., Wang, Z.-C., Liao, X.-F.
    Journal: Frontiers in Immunology
    Year: 2023

Assist Prof Dr. Zixing Wang | Epidemiology | Best Researcher Award

Assist Prof Dr. Zixing Wang | Epidemiology | Best Researcher Award

Peking University People’s Hospital | China

AUTHOR PROFILE

Scopus

 

🌿ASSIST PROF DR. ZIXING WANG 🌿

πŸ“˜EDUCATION

  1. πŸŽ“ Ph.D. in Epidemiology and Biostatistics
    Peking Union Medical College (2013-09 to 2019-07)
  2. πŸ“œ Bachelor’s Degree in Preventive Medicine
    Hebei Medical University (2008-09 to 2013-07)

πŸ§ͺEARLY ACADEMIC PURSUITS

Zixing Wang embarked on his academic journey with a Bachelor’s degree in Preventive Medicine from Hebei Medical University, where he developed a strong foundation in public health and disease prevention. He then pursued a Ph.D. in Epidemiology and Biostatistics at Peking Union Medical College, deepening his expertise in statistical methods and epidemiological research.

πŸ”¬PROFESSIONAL ENDEAVORS

Zixing Wang’s professional career began as an Assistant Researcher at the Chinese Academy of Medical Sciences, where he served from August 2019 to July 2022. He was then promoted to Associate Researcher at the same institution, a role he held until February 2024. Currently, he is an Assistant Professor at Peking University and an Associate Researcher at Peking University People’s Hospital, positions he has held since March 2024.

πŸ“Š CONTRIBUTIONS AND RESEARCH FOCUS ON EPIDEMIOLOGY

Wang’s research primarily focuses on the application of machine learning in medical imaging and predictive modeling for diseases. He has led multiple significant projects, including those funded by the National Natural Science Foundation of China and Peking Union Medical College Hospital. His notable projects include:

  1. πŸ“Š Recognition of Lung Nodule Evolution Patterns Based on Delta Imaging Omics and Dynamic Decision-making for Follow-up Timing (2024-01-01 to 2026-12-31)
  2. 🧠 Study on Prediction Model of Female Urinary Incontinence Outcome Based on Machine Learning (2022-07 to 2024-12)
  3. 🩺 Establishment of HRCT Features and Evaluation System for Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease Using Deep Learning (2022-07 to 2024-12)
  4. πŸ€– Exploration of Reinforcement Learning Methods for Individualized Follow-up Timing Schemes for Lung Nodule Patients (2021-01 to 2022-12)
  5. πŸ”¬ Research on Gradient Boosting Algorithm for Discrimination Diagnosis of Lung Cancer Based on Dual-energy CT Fractal Dimension (2016-10 to 2018-10)

🩺IMPACT AND INFLUENCE

Wang’s research has significantly impacted the fields of epidemiology and biostatistics, particularly in the use of advanced imaging techniques and machine learning for disease prediction and diagnosis. His work on lung nodule evolution patterns and predictive models for urinary incontinence and interstitial lung disease has advanced clinical practices and decision-making processes.

πŸ“šACADEMIC CITES

Zixing Wang has an extensive list of publications in high-impact journals, contributing to his recognition and citation in the academic community. His work is frequently cited by peers, reflecting the influence and relevance of his research in the scientific field.

πŸ‘©β€πŸ”¬LEGACY AND FUTURE CONTRIBUTIONS

Wang’s legacy lies in his pioneering research and the development of innovative methodologies in medical imaging and disease prediction. As he continues his work at Peking University and Peking University People’s Hospital, his future contributions are expected to further advance the field of epidemiology and biostatistics, particularly through the integration of machine learning and artificial intelligence in medical research.

πŸ“œOTHER IMPORTANT TOPICS

🌟GRANTS AND PROJECT FUNDING Wang has successfully secured funding for numerous research projects, demonstrating his capability to lead and manage large-scale studies. His ability to obtain grants from prestigious institutions underscores the significance and potential impact of his research.

πŸ†TEACHING AND MENTORSHIP In his role as an Assistant Professor, Wang is committed to educating the next generation of researchers. He actively mentors students, guiding them in their academic and research pursuits, and fostering a collaborative and innovative learning environment.

🏒INTERDISCIPLINARY COLLABORATIONS Wang collaborates with experts across various disciplines, enhancing the interdisciplinary nature of his research. These collaborations enable the integration of diverse perspectives and expertise, contributing to the robustness and applicability of his findings.

By highlighting Zixing Wang’s comprehensive academic journey, professional achievements, and impactful contributions, this resume encapsulates his significant role in advancing the fields of epidemiology and biostatistics. His continued dedication to research and education promises a lasting legacy and future innovations in medical science

 

πŸ“ŠπŸ”¬Notable Publication:

 

Prevalence and Patterns of Multimorbidity in China During 2002–2022: A Systematic Review and Meta-Analysis

  • Authors: Hu, Y., Wang, Z., He, H., …, Tu, J., Shan, G.
    Journal: Ageing Research Reviews
  • Year: 2024

Spatial Association of Surface Water Quality and Human Cancer in China

  • Authors: Wang, Z., Gu, W., Guo, X., …, Du, J., Jiang, J.
    Journal: npj Clean Water
  • Year: 2023

Assessment of the Spatial Association Between Multiple Pollutants of Surface Water and Digestive Cancer Incidence in China: A Novel Application of Spatial Machine Learning

  • Authors: Gu, W., Xue, F., Han, W., …, Yang, C., Jiang, J.
    Journal: Ecological Indicators
  • Year: 2023

Prognostic and Predictive Value of Interstitial Lung Abnormalities and EGFR Mutation Status in Patients with Non-Small Cell Lung Cancer

  • Authors: Xu, X., Zhu, M., Wang, Z., …, Zhang, Y., Gao, Y.L.
    Journal:Cancer Imaging
  • Year: 2024

Reinforcement Learning for Individualized Lung Cancer Screening Schedules: A Nested Case–Control Study

  • Authors: Wang, Z., Sui, X., Song, W., …, Hu, Y., Jiang, J.
    Journal: Cancer Medicine
  • Year: 2024